Yatharth Hospital & Trauma Care Services Limited

NSE: YATHARTH · Healthcare

₹1,026.95-0.03%06 Nov 2026

Ask the data

Instant answers about Yatharth Hospital & Trauma Care Services Limited — computed from its filings, no language model

Market cap₹9,895 cr

Current price₹1,026.95

High / Low₹1,162 / ₹551

P/E52.7

P/B5.28

Book value₹194.7

ROE10.0%

ROCE11.0%

Debt / equity0.24

Dividend yield—

EPS (TTM)₹19.48

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY24	FY25	FY26
Revenue	671	880	1,207
EBITDA	180	220	292
Operating margin	26.8%	25.0%	24.2%
Interest	9	8	7
Depreciation	29	57	88
Profit before tax	157	172	224
Tax	42	41	53
Net profit	114	0	170
EPS ₹	14.46	14.72	18.20
Operating cash flow	-3	150	205
Capex	93	311	317
Dividend paid	0	0	0
Total assets	1,019	1,731	2,282
Equity	874	1,605	1,807

Quarterly performance

last 14 quarters · ₹ crore

showing latest 8 of 14 periods

	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	155	171	167	178	212	218	219	232	258	279	320	342	393	431
Operating profit	41	46	46	47	54	55	55	57	64	65	74	80	92	102
Operating margin	26.8%	26.6%	27.8%	26.2%	25.3%	25.1%	25.1%	24.6%	25.0%	23.1%	23.2%	23.4%	23.3%	23.6%
Other income	1	4	5	6	4	3	4	5	9	9	8	7	4	5
Interest	6	3	0	0	3	2	2	1	0	0	1	5	7	8
Depreciation	7	7	8	8	11	16	17	13	15	19	24	30	28	33
Profit before tax	29	40	44	44	43	40	40	49	59	55	57	52	61	66
Tax	10	12	14	6	13	9	10	10	17	14	14	7	16	17
Net profit	19	28	29	38	0	31	30	0	42	41	45	45	47	51
EPS ₹	2.91	3.80	3.83	4.85	3.54	3.59	3.57	4.37	4.36	4.28	4.71	4.93	4.88	5.25
Revenue YoY	—	—	—	—	37.1%	27.1%	31.4%	30.4%	21.7%	28.3%	46.2%	47.4%	52.3%	54.4%
Profit YoY	—	—	—	—	-100.0%	12.1%	3.4%	-100.0%	—	33.2%	48.7%	—	11.9%	22.7%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 11 periods

	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	13.1%	10.9%	10.6%	10.7%	3.8%	6.4%	6.7%	7.6%	9.6%	9.9%	10.0%
ROCE	17.4%	18.5%	17.2%	17.0%	11.2%	12.0%	12.0%	13.0%	11.1%	11.6%	11.0%
Net margin	17.1%	13.1%	12.8%	12.1%	7.0%	11.2%	11.5%	11.8%	14.5%	13.4%	12.6%
EBITDA margin	26.8%	26.4%	26.0%	25.4%	25.0%	24.9%	24.4%	23.9%	23.6%	23.3%	23.4%
Debt / equity	0.09	0.09	0.10	0.10	0.00	0.00	0.01	0.01	0.14	0.14	0.24
Interest coverage	17.65	27.59	34.98	25.18	23.87	40.22	59.10	90.81	35.03	18.39	12.25
Asset turnover	0.66	0.71	0.71	0.76	0.51	0.54	0.53	0.59	0.53	0.58	0.57

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 7 periods

	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	86	86	86	96	96	96	96
Other equity / reserves	721	788	846	1,509	1,592	1,711	1,779
Total equity	806	874	932	1,605	1,689	1,807	1,876
Borrowings	11	83	90	0	20	253	451
Current liabilities	43	67	73	85	93	184	268
Non-current liabilities	5	78	88	9	43	290	424
Total assets	854	1,019	1,093	1,731	1,856	2,282	2,591
Property, plant & equipment	247	381	447	493	741	902	1,017
Capital work-in-progress	6	0	2	222	110	102	242
Investments	0	0	0	74	21	2	2
Inventories	6	8	14	21	29	21	23
Receivables	174	227	259	307	339	375	464
Cash & equivalents	86	113	156	362	173	221	276

Cash flow

annual · ₹ crore · line = free cash flow

	FY24	FY25	FY26
Cash from operations	-3	150	205
Cash from investing	-226	-420	-598
Cash from financing	304	520	254
Capex	93	311	317
Free cash flow	-96	-161	-112
Dividends paid	0	0	0

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹1,017 cr39%

CWIP

₹242 cr9%

Investments

₹2 cr0%

Inventories

₹23 cr1%

Receivables

₹464 cr18%

Cash & equivalents

₹276 cr11%

Other assets

₹567 cr22%

Peer comparison

largest in Healthcare · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Sun Pharmaceutical Industries Ltd.	4,46,270	1,860.00	40.7	5.00	12.3%
Divi's Laboratories Ltd.	2,73,493	10,320.50	93.5	16.32	17.5%
Torrent Pharmaceuticals Ltd.	1,80,671	4,750.00	85.1	9.83	11.6%
Laurus Labs Ltd.	1,26,430	2,340.00	94.4	20.86	22.1%
Apollo Hospitals Enterprise Ltd.	1,21,453	8,446.00	54.2	11.45	21.1%
Zydus Lifesciences Ltd.	1,19,550	1,197.90	28.6	4.30	15.0%
Dr. Reddy's Laboratories Ltd.	1,14,646	1,373.00	40.9	2.95	7.2%
Cipla Ltd.	1,13,988	1,411.00	39.3	3.22	8.2%
Mankind Pharma Ltd.	1,04,902	2,540.00	46.7	5.97	12.8%
Aurobindo Pharma Ltd.	1,03,572	1,800.00	26.0	2.63	10.1%
Yatharth Hospital & Trauma Care Services Limited	9,895	1,026.95	52.7	5.28	10.0%

StoxGud checklist: Bullish setup · 8/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-0.6%

6 months+24.9%

1 year+29.1%

3Y CAGR+40.2%

5Y CAGR—

10Y CAGR—

50-day avg₹1,006.99

200-day avg₹823.96

RSI (14)57

FAQs

What is the share price of Yatharth Hospital & Trauma Care Services Limited?

Yatharth Hospital & Trauma Care Services Limited (YATHARTH) closed at ₹1,026.95 on NSE on 06 Nov 2026.

What is the market cap of Yatharth Hospital & Trauma Care Services Limited?

₹9,895 crore at the latest close.

What is the P/E ratio of Yatharth Hospital & Trauma Care Services Limited?

52.7, on trailing-twelve-month earnings from its filings.

How fast is Yatharth Hospital & Trauma Care Services Limited growing?

Yatharth Hospital & Trauma Care Services Limited: Latest-quarter revenue is up 54.4% year on year, profit up 22.7%.

How profitable is Yatharth Hospital & Trauma Care Services Limited?

On a trailing-twelve-month basis return on equity is 10.0%, return on capital employed 11.0%, operating margin 23.4%, net margin 12.6%.

How much debt does Yatharth Hospital & Trauma Care Services Limited have?

Yatharth Hospital & Trauma Care Services Limited is lightly geared: debt to equity is 0.24 with borrowings of ₹451 cr against cash of ₹276 cr (balance sheet of 2026-09-30). Operating profit covers interest 12.2 times.

Financials parsed from Yatharth Hospital & Trauma Care Services Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from JUN '23, annual from FY24, balance sheet from Sep '23. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.